Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
Notice NOT-OD-23-126 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 5, 2023 Category: Research Source Type: funding
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-035 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2023 Category: Research Source Type: funding
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-034 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (NOFO) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this NOFO is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This NOFO is expected to promote partnerships between Federally-funded SBIR or STTR Phase II ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2023 Category: Research Source Type: funding
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
Funding Opportunity RFA-DA-24-038 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) proposing research projects directed towards commercialization for the development of novel, evidence-based, FDA-regulated medical products addressing the needs of patients suffering from opioid use disorders (OUD) and/or stimulant use disorders (StUD). Applications received under this NOFO may fall within two scientific areas, namely: (1) pharmacotherapeutics (small molecules and biologics)and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2023 Category: Research Source Type: funding
Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-23-008 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to develop resources, new methods, and approaches that can be applied in testing strategies to help understand the role of environmental chemicals in the etiology of the neurodevelopmental disorders. There is a need for novel and innovative approaches including New Approach Methodologies (NAMs) that can provide effecti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2023 Category: Research Source Type: funding
Preparing a Small Business Application Involving Vertebrate Animals
Are you an NIH small business (SBIR/STTR) applicant whose research involves the use of live vertebrate animals? If so, access these resources from the recent Preparing a Small Business Application Involving Vertebrate Animals webinar to learn how to complete your grant application or contract proposal.
This presentation from the Office of Laboratory Animal Welfare assists small business applicants with understanding requirements and applicable regulations and how to avoid potential pitfalls during the application and award process.
Watch the webinar recording.
Access the transcript.
Access the slide deck.
Access the he...
Source: NIH Extramural Nexus - March 16, 2023 Category: Research Authors: NIH Staff Tags: New Resources small business Source Type: funding
Notice of Request for Proposals (RFP), Solicitation 75N91023R00034: NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT AWARD PROGRAM
Notice NOT-CA-23-050 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2023 Category: Research Source Type: funding
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-23-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Technology-enhanced training products for the health and safety training of: hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biological hazard response, infectious disease response, and medical waste cleanup; emergency responders in disasters; and...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2023 Category: Research Source Type: funding
FY 2022 By the Numbers: Extramural Grant Investments in Research
Today we present our annual snapshot of NIH grant funding and success rate data for fiscal year (FY) 2022 enacted appropriations. These data are available in the NIH Data Book, which is also being regularly updated with other FY 2022 grants information. Similar to our FY 2021 and FY 2020 posts, spending related to special appropriations for coronavirus are excluded here, but may be found using RePORTER’s advanced search capabilities.
In FY2022, NIH spent $33.3 billion of its total $45.2 billion appropriation for competing and noncompeting grant awards. This is a 3.1% increase (or $1.02 billion) in spending over the p...
Source: NIH Extramural Nexus - March 1, 2023 Category: Research Authors: Mike Lauer Tags: blog Open Mike awards grants Success Rate Source Type: funding
Notice of NIGMS Withdrawal of Participation from PA-22-177 "PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
Notice NOT-GM-23-032 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2023 Category: Research Source Type: funding
Notice of NIGMS Withdrawal of Participation from PA-22-179 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
Notice NOT-GM-23-033 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 22, 2023 Category: Research Source Type: funding
Take Advantage of Our Many Resources for Enhancing the Rigor of Animal Research
“Despite the numerous successes stemming from animal research, concerning reports over the past decade have described biomedical experiments that fail to replicate or to translate in ways that improve human health. All research is not expected to translate to human treatments, as there is no perfect model. Scientific process is as much about failure as it is about success. Yet part of the scientific process is also continual improvement, which includes working to understand what might contribute to unexpected outcomes within animal research.”
The Advisory Committee to the NIH Director (ACD) expressed that view in their...
Source: NIH Extramural Nexus - February 10, 2023 Category: Research Authors: Mike Lauer Tags: blog Open Mike Alternatives to Animals reproducibility rigor Source Type: funding
Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes
Notice NOT-AG-23-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2023 Category: Research Source Type: funding
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Funding Opportunity RFA-MD-23-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined population groups who experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable. (Source: NIH Funding Oppor...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2023 Category: Research Source Type: funding
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Funding Opportunity RFA-MD-23-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations experiencing health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2023 Category: Research Source Type: funding
